Effect of improvement in anemia on electroneurophysiological markers (P300) of cognitive dysfunction in chronic kidney disease
- 23 June 2006
- journal article
- Published by Wiley in Hemodialysis International
- Vol. 10 (3) , 267-273
Abstract
Our aim is to study the effect of improvement in anemia on event‐related potentials (ERPs; P300) as markers of cognitive dysfunction in predialysis and dialysis patients of chronic kidney disease (CKD). Thirty anemic patients of CKD (hemoglobin [Hb]<9 g%), 15 in the predialysis group (Group A), and 15 patients on biweekly hemodialysis (Group B) were recruited for the study. Patients of uremic encephalopathy, dyselectrolytemia, and those with hearing problems were excluded. Both groups were given recombinant human erythropoietin (rhuEPO) 100 IU/kg biweekly for 6 weeks by the subcutaneous route. No intervention was performed in the third control group (Group C), which consisted of 30 normal healthy volunteers. The improvement in Hb was assessed every 2 weeks, and the amplitude and latency of the P300 component of the ERPs were studied before initiating treatment and after 6 weeks of rhuEPO administration. There was a significant increase in Hb in both the study groups without any significant alteration in kidney functions. A significant reduction in P300 latency was noted in both the study groups after intervention. Similarly, the amplitude of P300 also increased in both study groups, but attained statistical significance for the dialysis group only. No significant changes were observed in the control group. Administration of EPO in patients of anemia with CKD resulted in a significant improvement in the electrophysiological markers of cognitive function in the form of increased amplitudes and decreased latencies of P300 in both predialysis and dialysis patients.Keywords
This publication has 9 references indexed in Scilit:
- Normalizing hematocrit in dialysis patients improves brain functionAmerican Journal of Kidney Diseases, 1999
- IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN committeeElectroencephalography and Clinical Neurophysiology, 1994
- Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failureKidney International, 1993
- Can the Nephrologist Prevent Dialysis-Related Amyloidosis?American Journal of Kidney Diseases, 1991
- rHuEPO treatment improves brain and cognitive function of anemic dialysis patientsKidney International, 1991
- Cognitive function, mood and P3 latency: Effects of the amelioration of anemia in dialysis patientsNeuropsychologia, 1991
- Improvement of brain function in hemodialysis patients treated with erythropoietinKidney International, 1990
- P3 and other Long Latency Auditory Evoked Potentials in Presenile Dementia Alzheimer Type and Alcoholic Korsakoff SyndromeThe British Journal of Psychiatry, 1985
- Quantitative indices of clinical uremiaKidney International, 1979